Neurite degeneration elicited by apolipoprotein E peptides

Experimental Neurology

Volumn 130, Issue 1, 1994, Pages 120-126

  Crutcher, Keith A ^a   Clay, Moira A ^a   Scott, Samuel A ^a   Tian, Xintian ^a   Tolar, Martin ^a   Harmony, Judith A K ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028557128     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1994.1191     Document Type: Article

References (30)

1. AVILA, E. M., G. HOLDSWORTH, N. SASAKI, R. L. JACKSON, and J. A. K. HARMONY. 1982. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J. Biol. Chem. 257: 5900-5909.
2. BOYLES, J. K., R. E. PITAS, E. WILSON, R. W. MAHLEY, and J. M. TAYLOR. 1985. Apolipoprotein E association with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 82: 1501-1513.
3. CARPENTER, M., KM K., A. CRUTCHER, and S. B. KATER. 1993. An analysis of the effects of Alzheimer's plaques on living neurons. Neurobiol. Aging. 14: 207-215.
4. CLAY, M. A., M. J. MISTRY, A. BALASUBRAMANIAM, and J. A. K. HARMONY, 1993. Localization of a domain in ApoE with cytostatic and cytotoxic activities. Circulation 88:1-133.
5. CORDER, E. H., A. M. SANDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES, and M. PERICAK-YANCE, 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
6. CURTISS, L. K., T. M. FORTE, and P. A. DAVIS. 1984. Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. J. Immunol. 133: 1379-1384.
7. DICCIANI, M. B., M. LILLY-STAUDERMAN, L. R. MACLEAN, A. BALASUBRAMANIAM, and J. A. K. HARMONY. 1991. Heparan prevents the binding of phospholipase A2 to phospholipid micelles: importance of the amino terminus. Biochemistry 30:1067-1077.
8. DYER, C. A., R. S. SMITH, and L. K. CURTISS. 1991. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J. Biol. Chem. 266: 15009-15015.
9. HANDELMANN, G. E., J. K. BOYLES, K. H. WEISGRABER, R. W. MAHLEY, and R. E. PITAS. 1992. Effects of apolipoprotein E, b-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33: 1677-1688.
10. IGNATIUS, M. J., E. M. SHOOTER, R. E. PITAS, and R. W. MAHLEY. 1987. Lipoprotein uptake by neuronal growth cones in vitro. Science 236: 959-962.
11. LAMPERT, P. 1971. Fine structural changes of neurites in Alzheimer's disease. Acfa Neuropathol. Suppl. 5; 49-53.
12. MAHLEY, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
13. MOBLEY, W. C., A. SCHENKER, and E. M. SHOOTER. 1976. Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 15: 5543-5552.
14. NAMBA, Y., M. TOMONAGA, H. KAWASAKI, E. OTOMO, and K. IKEDA. 1991. Apolipoprotein E immu noreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jacob disease. Brain Res. 541:163-166.
15. NATHAN, B. P., S. BELLOSTA, D. A. SANAN, K. H. WEISGRABER, R. W. MAHLEY, and R. E. PITAS. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264: 850-852.
16. NOGUCHI, S., K. MURAKAMI, and N. YAMADA. 1993. Apolipoprotein E genotype and Alzheimer's disease (letter). Lancet 342: 737.
17. PAYAMI, H., J. KAYE, L. L. HESTON, T. D. BIRD, and G. D. SCHELLENBERG. 1993. Apolipoprotein E genotype and Alzheimer's disease (letter). Lancet 342: 738.
18. POIRIER, J., J. DAVIGNON, D. BOUTHILLIER, S. KOGAN, P. BERTRAND, and S. GAUTHIER. 1993. Apolipoprotein E genotype and Alzheimer's disease (letter). Lancet 342:697-699.
19. PROBST, A., V. BASLER, B. BRON, and J. ULRICH. 1983. Neuritic plaques in senile dementia of Alzheimer type: A golgi analysis in the hippocampal region. Brain Res. 268: 249-254.
20. REBECK, G. W., J. S. REITER, D. K. STRICKLAND, and B. T. HYMAN. 1993. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11: 575-580.
21. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST. GEORGE-HYSLOP, M. PERICAK-VANCE, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACHLAN, M. J. ALBERTS, C. HU-LETTE, B. CRAIN, D. GOLDGABER, and A. D. ROSES. 1993. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
22. SAUNDERS, A. M., K. SCHMADER, J. C. S. BREITNER, M. D. BENSON, W. T. BROWN, L. GOLDFARB, D. GOLDGABER, M. G. MANWARING, M. H. SZYMANSKI, N. MCCOWN, K. C. DOLE, D. E. SCHMECHEL, W. J. STRITTMATTER, M. A. PERICAK-VANCE, and A. D. ROSES. Apolipoprotein E e4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711.
23. SCOTT, S. A., S. LIANG, J. A. WEANGARTNER, and K. A CRUTCHER. Increased NGF-like activity in young but not aged rat hippocampus after septal lesions. Neurobiol. Aging 15: 337-346.
24. SONIAT, T. L. L. 1941. Histogenesis of senile plaques. Arch. Neurol. Psychiatr. 46: 101-114.
25. STRITTMATTER, W. J., A. M. SANDERS, D. SCHMECHEL, M. PERICAK-VANCE, J. ENGHILD, G. S. SALVESEN, and A. D. ROSES. 1993. Apolipoprotein E: High avidity binding to p-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
26. STRITTMATTER, W. J., K. H. WEISGRABER, D. Y. HUANG, L.-M. DONG, G. S. SALVESEN, M. PERICAK-VANCE, D. SCHMECHEL, A. M. SANDERS, D. GOLDGABER, and A. D. ROSES. 1993. Binding of human apolipoprotein E to synthetic amyloid 3-peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102.
27. WHITSON, J. S., D. J. SELKOE, and C. W. COTMAN. 1989. Amyloid p protein enhances the survival of hippocampal neurons in vitro. Science 243:1488-1490.
28. WISNIEWSKI, T., and B. FRANGIONE. 1992. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135: 235-238.
29. WISNIEWSKI, T., A. GOLABEK, E. MATSUBARA, J. GHISO, and B. FRANGIONE. 1993. Apolipoprotein E: Binding to soluble Alzheimer's p-amyloid. Biochem. Biophys. Res. Commun. 192: 359-365.
30. YANKNER, B., L. DUFFY, and D. KIRSCHNER. 1990. Neurotrophic and neurotoxic effects of amyloid p protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.